Tyrosinaemia Type 1 is a rare life-threatening genetic disorder present from birth. In Tyrosinaemia Type 1, the body is unable to break down an amino acid called tyrosine. This causes a build up of tyrosine and another chemical called succinylacetone in the liver, kidneys, eyes and brain and can cause problems.
At present, the treatment for Tyrosinaemia Type 1 consists of a medication called nitisinone (NTBC) together with a protein restricted diet for life and taking regular dietary supplements which contain amino acids, vitamins and minerals.
Patients with Tyrosinaemia Type 1 are managed by the multidisciplinary team and we liaise closely with the Metabolic Laboratory to ensure close and frequent monitoring of these patients. We follow international best practise guidelines in managing our patients with Tyrosinaemia Type 1. We collaborate with our international colleagues in the management of our patients with Tyrosinaemia Type 1.
Tyrosinaemia Dietary Handbook
1g Exchange list 2017
Slightly higher exchange list 2017-for those on more than 7 exchanges
Super high exchange list 2017-for those on more than 20 exchanges
Low Protein Manufactured Food List 2017
Reading food labels for Tyrosinaemia
Weaning your baby on a Tyrosinaemia diet